ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Program Announcement In Preventative Oncology

May 21, 1982

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

NCAB Member David Koch Gives $100 Million To MIT For New Cancer Research Institute.

October 12, 2007

Adamson Objects to IOM “Primrose Path of Centralization” In Report

March 3, 1989

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997